Aug 5, 2026 07:09AM
Aug 5, 2026 07:00AM
May 5, 2026 07:33AM
May 5, 2026 07:00AM
Mar 12, 2026 07:00AM
Mar 2, 2026 04:06PM
Mar 2, 2026 04:05PM Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Nov 5, 2025 07:17AM
Nov 5, 2025 07:00AM
Oct 30, 2025 07:00AM
Aug 6, 2025 07:52AM
Aug 6, 2025 07:00AM
Jul 22, 2025 07:01AM
May 8, 2025 05:06AM Chardan Capital Markets Downgrades Seres Therapeutics (MCRB) to Neutral
May 7, 2025 07:00AM
Apr 23, 2025 07:00AM
Mar 13, 2025 07:06AM
Mar 13, 2025 07:00AM
Mar 4, 2025 07:00AM
Jan 9, 2025 07:00AM
Nov 13, 2024 07:36AM Seres Therapeutics (MCRB) Misses Q3 EPS by 25c
Nov 13, 2024 07:00AM
Nov 6, 2024 07:00AM
Aug 13, 2024 07:03AM
Aug 13, 2024 07:00AM
Aug 6, 2024 07:00AM
May 8, 2024 07:00AM
May 6, 2024 09:30AM Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
Mar 5, 2024 07:00AM
Feb 28, 2024 07:00AM
Nov 2, 2023 07:17AM
Nov 2, 2023 07:00AM
Oct 30, 2023 05:30PM
Aug 8, 2023 07:09AM
Aug 8, 2023 07:00AM Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
Aug 1, 2023 07:00AM
May 9, 2023 07:52AM
May 9, 2023 07:00AM
May 9, 2023 07:00AM
May 9, 2023 07:00AM
May 5, 2023 07:00AM
Mar 7, 2023 07:00AM Seres Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
Feb 28, 2023 07:00AM
Nov 2, 2022 07:00AM
Oct 27, 2022 07:00AM
Aug 3, 2022 07:00AM
Jul 28, 2022 07:00AM
May 4, 2022 07:17AM
May 4, 2022 07:00AM Seres Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
Apr 28, 2022 07:00AM

1,216,193 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All